Anavex Life Sciences Corp (AVXL)

[Investor2014]

Maybe you were thinking of Monday's presentation.

Anavex Life Sciences to Present at Cowen and Company 38th Annual Health Care Conference

NEW YORK , March 06, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Rett syndrome and other central nervous system (CNS) diseases, announced today that its President and Chief Executive Officer, Christopher U. Missling, PhD, will present at the Cowen and Company 38th Annual Health Care Conference on Monday, March 12, 2018 at 2:10 pm ET at the Marriott Copley Place in Boston, MA.


A live webcast of the presentation will be available on http://wsw.com/webcast/cowen46/avxl/. A replay will be available via www.anavex.com and will be accessible for three months following the presentation.